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Singlet oxygenOne of the current goals in photodynamic therapy research is to enhance the selective targeting of tumor cells
in order to minimize the risk and the extension of unwanted side-effects caused by normal cell damage.
Special attention is given to receptor mediated delivery systems, in particular, to those targeted to folate
receptor. Incorporation of a model photosensitizer (ZnTPP) into a folate-targeted liposomal formulation has
been shown to lead an uptake by HeLa cells (folate receptor positive cells) 2-fold higher than the non-targeted
formulation. As a result, the photocytotoxicity induced by folate-targeted liposomes was improved. This
selectivity was completely inhibited with an excess of folic acid present in the cell culture media. Moreover,
A549 cells (folate receptor deﬁcient cells) have not shown variations in the liposomal incorporation.
Nevertheless, the differences observed were slighter than expected. Both folate-targeted and non-targeted
liposomes localize in acidic lysosomes, which conﬁrms that the non-speciﬁc adsorptive pathway is also
involved. These results are consistent with the singlet oxygen kinetics measured in living cells treated with
both liposomal formulations.Dulbecco's Modiﬁed Eagle's
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Photodynamic therapy (PDT) is an emerging modality for the
treatment of various ophthalmic, dermatologic, cardiovascular, and
predominantly, oncologic diseases, that involves light, a photosensi-
tizer (PS) and tissue oxygen, all innocuous for the cells by themselves
[1–4]. The combined action of the triplet state of the PS and molecular
oxygen results in the formation of singlet oxygen (1O2) a reactive
oxygen species (ROS) which is thought to be the main responsible of
photo-induced cell death, playing a key role in both apoptotic and
necrotic pathways [5–7]. Once produced, 1O2 may diffuse away from
the site of production; oxidize biomolecules encountered along itspath, or decay back to the ground state within its lifetime. The tiny
fraction of 1O2 which undergoes radiative decay emitting at 1280 nm
is employed for optical 1O2 detection. The time-resolved measure-
ment of this emission is a very well-established method for
monitoring 1O2 production and determining its lifetime [8,9].
One of the most actively pursued goals in PDT research is to
enhance the selective targeting of tumor cells in order tominimize the
risk and extension of unwanted side-effects caused by damage to
normal tissues [10]. Targeted drug delivery systems are one of the
strategies proposed to solve the problems underlying traditional
cancer treatments. Drug delivery systems are able to modify the
pharmacokinetics and biodistribution of their associated drugs. In this
way, liposomes possess many interesting properties such as the
ability to entrap both hydrophilic and hydrophobic drug molecules
without loss or alteration of their activity, long systemic circulation
times, preferential accumulation in solid tumors, and controlled drug
release [11–13]. In PDT, it has been shown that liposomes increase the
photosensitizing efﬁciency of some PDT agents by maintaining their
monomeric form, by modifying the uptake of the dye by malignant
cells, or by inﬂuencing their subcellular accumulation [14,15].
One approach to improve the therapeutic efﬁcacy of drug-carrying
liposomes is the grafting of tumor-speciﬁc ligands to their lipid
bilayer, which can be recognized by speciﬁc cell surface components
[16], e.g., antibodies [17], growth factors [18], glycoproteins
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ligand-targeted therapies not only facilitates targeting to the cell but
also drug retention at the target site by preventing the rapid
elimination from the system circulation. These ligands represent a
minimal risk of inducing immune response, are widely available and
often inexpensive. At present, special attention is given to folate
receptor (FR)-mediated delivery systems [21]. Folic acid is an
essential vitamin for the proliferation and maintenance of all cells.
The lack of this nutrient in human serummakesmalignant cells to up-
regulate this receptor to compete more aggressively for the vitamin.
The overexpression of folate receptor on a variety of epithelial cancer
cells including cancers of ovary, lung, kidney, breast, brain and colon
[22], and the extremely high afﬁnity of folate for its receptor provide a
novel approach to speciﬁcally deliver PSs encapsulated in folate-
functionalized liposomes in vitro [23]. Improved uptake of PS-folate
conjugates has been reported previously [24,25] and different
systemic carrier platforms have been developed to achieve selective
accumulation of PSs [26–30]. However, the details of such improved
PS uptake are poorly understood. For instance, to what extent does
receptor-mediated uptake affect the accumulation of PSs in the cells?
Does receptor-mediated uptake affect the localization of the PSs in the
cells? Are the photosensitization properties affected?
In order to address these questions, the model PS zinc-
tetraphenylporphyrin (ZnTPP) was encapsulated in folate-targeted
and non-targeted liposomes to assess the role of folate receptors in
the active uptake of folate-targeted liposomes. ZnTPP was chosen as
PS as it can be conveniently encapsulated in liposomes in high yield
and inmonomeric state [31,32]. Our results show that targeting HeLa
cells (FR-overexpressing cervical carcinoma cell line) with folate-
decorated liposomes indeed leads to an increased PS uptake. This
enhancement induces higher photodynamic cell death compared to
that caused by incubation with non-targeted liposomes. We
subsequently describe a comparative study of accumulation and
phototoxicity in FR-expressing HeLa tumor cells, and in A549 tumor
cells which do not express FR. Subcellular localization patterns of
both formulations were studied, as well as 1O2 kinetics measured in
living cells.
2. Materials and methods
2.1. Chemicals
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-
dioleoyl-sn-glycero-3-[phospho-L-serine] (sodium salt) (OOPS) and
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(poly-
ethylene glycol)-2000] (ammonium salt) (FA-PEG-DSPE) were
purchased from Avanti Polar Lipids (Birmingham, AL, USA). Imidazole,
folic acid and 5,10,15,20-tetraphenyl-21H,23H-porphine zinc (ZnTPP)
were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO,
USA). The porphyrin used had a minimal purity of 99% and was used
as received. Deuterium oxide (99.9%) was purchased from Solvents
Documentation Synthesis (SDS, Peypin, France). All other chemicals
were commercially available reagents of at least analytical grade.
Milli-Q water (Millipore Bedford, Massachusetts system, resistivity of
18 MΩ cm) was used.
Dulbecco's Modiﬁed Eagle's Medium (DMEM) with 4.5 g/L glucose,
folate-deﬁcient DMEM with 4.5 g/L glucose (FD-DMEM), fetal bovine
serum (FBS), penicillin–streptomycin solution and L-glutamine solution
for biological assayswere purchased fromBiological Industries (Kibbutz
Beit Haemek, Israel). Sterile Dulbecco's phosphate-buffered saline (PBS)
and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) were purchased from Sigma-Aldrich. MicroBCA protein assay
kit was purchased from Pierce Protein Research Products (Rockford, IL,
USA) and used according to the product information sheet. The
sterilized material was purchased from Techno Plastic Products
(Trasadingen, Switzerland).2.2. Cell cultures
Human HeLa cervical adenocarcinoma cell line (ATCC CCL-2) is
one of the many tumor cell types that are known to over-express
folate receptors [33]. Human lung adenocarcinoma A549 cells (ATCC
CCL-185), known to be deﬁcient in FR expression, were used as
negative control. HeLa and A549 cells are adherent cells which grow
up to form cellular monolayers toward conﬂuence after seeding.
These cells were cultured at 37 °C in a humidiﬁed sterile atmosphere
of 95% air and 5% CO2, using DMEM supplemented with fetal bovine
serum (10% v/v), glucose (4.5 g/L), L-glutamine (292 mg/L), strepto-
mycin sulfate (10 mg/L) and potassium penicillin (10,000 U/L). Before
the experiments the cells were subcultured in folate-deﬁcient DMEM
(FD-DMEM) supplemented with the same components as DMEM for
2 weeks to establish a folate deﬁciency. Cell lines were maintained
frozen in DMEM with 10% DMSO. 1.8 mL CryoTubes™ (Nunc, Nalge
Nunc International, IL, USA) were ﬁlled with the cell suspension and
placed in a cell Cryo 1 °C Freezing Container (Nalgene, Nalge Nunc
International, IL, USA) to be slowly frozen up to −80 °C at a cooling
rate of −1 °C/min for successful cell cryopreservation. Frozen cells
were rapidly transferred to a liquid nitrogen container (−196 °C) and
stored.
2.3. Preparation of liposomes
Folate-targeted and non-targeted liposomes for porphyrin incor-
poration were prepared by microemulsiﬁcation following standard
procedures [31,32]. Brieﬂy, POPC/OOPS (90:10 molar ratio, non-
targeted liposomes) and POPC/OOPS/FA-PEG-DSPE (90:10:0.1 molar
ratio, FR-targeted liposomes) mixtures containing the photosensitizer
ZnTPP at 100:1 lipid/porphyrin molar ratio were evaporated to
dryness from a chloroform solution and kept in a vacuum desiccator
for 12 h over P2O5 in order to remove the last traces of the solvent.
Multilamellar vesicles (MLVs) were prepared by hydratation of the
dried lipid ﬁlms by vortexing for 30 min (alternating 30 s periods of
heating and 30 s of vortexing) at a concentration of 20 mg lipid/mL of
50 mM imidazole–HCl buffer (pH 7.4) at 45 °C. The MLVs dispersion
was frozen and thawed (ﬁve times), sonicated (bath sonicator,
15 min, 45 °C) and microemulsiﬁed (EmulsiFlex B3 device, Avestin,
Ottawa, Canada). Microemulsiﬁcationwas carried out by pumping the
ﬂuid ﬁfteen times through the interaction chamber (45 °C, 200 kPa).
Control liposomes were prepared in the same way but without the PS.
The liposomes were stored in the dark at 4 °C. Subsequent liposome
handling procedures were all performed in the dark.
2.4. Liposome characterization
The PS and the lipid content in the liposomes were evaluated
following standard procedures. Liposomes were disrupted by the
addition of THF to an aliquot of the liposomal suspension, free of non-
entrapped PS, obtained in imidazole–HCl buffer (THF/imidazole–HCl
buffer, 24/1, v/v) and the absorbancewasmeasured at λmax of the Soret
band. The PS concentration was determined by comparison with
standard curves obtained in the same conditions. Lipid content was
quantiﬁed by a colorimetric assay with ammonium ferrothiocyanate
according to the method of Stewart [34]. The average size and
polydispersity of unilamellar vesicles and the zeta potential were
determined by photon correlation spectroscopy (PCS). A Zetasizer
Nano-ZS (Malvern Instruments, UK) and a 4 mWHe−Ne laser (Spectra
Physics), at an excitation wavelength of 633 nm, were used. Before
measuring, samples were appropriately diluted to avoid multiple
scattering. To control the stability of the formulations, the PS and lipid
content in liposomes aswell as the average size andpolydispersity of the
vesicles were also determined after storage up to 7 days.
The stability of liposomes was also tested in the presence of 10%
FBS following the procedure described in [35]. Liposomal suspensions
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in imidazole–HCl buffer with 10% FBS at 37 °C with continuous
stirring for different periods of time up to 48 h. After each incubation
period, 200 μL of the mixtures were withdrawn and centrifuged at
4000 rpm to eliminate any non-encapsulated PS, appeared as a result
of the disruption of the liposomes due to its interaction with serum
components. Then, 1.5 mL of THF was added to 50 μL of each
supernatant to disrupt the liposomes, liberating the porphyrin still
encapsulated in the liposomes and precipitating the serum compo-
nents. These samples were centrifuged at 4000 rpm to obtain a clear
supernatant and the absorption spectra were recorded.
2.5. Dark toxicity and cell uptake
To select the ZnTPP concentration in cell cultures for uptake
experiments, the PS dark toxicity was determined after incubation
with 1–50 μM ZnTPP for up to 24 h. Cell viability was evaluated 24 h
after treatment by the MTT colorimetric assay [36]. Brieﬂy, after
washing with PBS, DMEM containing 0.5 mg/mL MTT was added and
incubated for 1 h at 37 °C. Themediumwas replaced by DMSO and the
absorbance at 550 nm was read on a Bio-Rad Benchmark Plus
microplate reader.
A concentration of 10 μMZnTPPwas chosen as a good compromise
between cell viability and PS concentration in culture medium, with
survival fractions higher than 85% for non-targeted and folate-
targeted formulations, for both cell lines. The cellular uptake of
ZnTPP was determined by ﬂuorescence spectroscopy. HeLa and A549
cells were seeded in 25 cm2 tissue culture ﬂasks and grown toward
80–85% conﬂuence in FD-DMEM. Cells were incubated in the dark
with the appropriate volume of the folate-deﬁcient medium contain-
ing 10 μM ZnTPP encapsulated in the two different liposomal
formulations, for different times ranging from 30 min to 24 h. In
free folate competition studies, 1 mM folic acid was added to the
incubation medium. Afterwards, the medium was discarded and the
cells were washed three times with PBS, scrapped and resuspended in
1 mL of 2% sodium dodecyl sulfate (SDS) in Milli-Q water. The
resulting suspension was centrifuged at 10,000 rpm for 10 min
(Sigma 2-16P centrifuge, angle rotor 24×1.5/2.2 mL). The extent of
PS uptake was assessed by comparison between the ﬂuorescence of
this supernatant to that of standard solutions under the same
conditions. The ﬂuorescence intensity values obtained for each
sample were normalized to the number of cells determined by the
bicinchoninic acid (BCA) protein assay [37]. Each experiment was
repeated twice.
In order to study the liposome cell internalization [38] and to
distinguish surface bound to internalized liposomes, HeLa cells were
incubated either at 4 °C (where folate-receptor-mediated endocytosis
is blocked [23,39]) or 37 °C in the dark for 4 h with FD-DMEM
containing 10 μM ZnTPP encapsulated in non-targeted and FR-
targeted liposomes. Since folate rapidly dissociates from speciﬁc,
high-afﬁnity binding factors in acid pH [40], we used an acidic saline
wash to remove surface-bound liposomes and distinguish the uptake
due to surface binding than that due to internalization. After rising
with PBS, cells were incubated for 10 min with acetate buffer pH 3.5
(130 mM NaCl, 20 mM NaAc). Cells were then scrapped and
resuspended in 1 mL of 2% SDS. The extent of PS uptake was assessed
by the same procedure described above.
2.6. Subcellular localization and quantitative analysis
Folate-deﬁcient HeLa cells were grown on 22 mm square cover-
slips placed into 35 mm culture dishes. They were incubated at 37 °C
for 24 or 48 h with FD-DMEM containing 1 or 10 μM ZnTPP
encapsulated in folate-targeted or non-targeted liposomes. Cells
were washed four times with PBS, mounted in DMEM and observed
immediately. Microscopic observations and photography were per-formedwith a Leica TCS SP2 confocalmicroscope (Wetzlar, Germany),
operating with the 561 nm laser line. To conﬁrm the intracellular
localization of ZnTPP, the endocytic compartments of the HeLa cells
were labeled with the ﬂuoroprobe LysoTracker Red DND-99 (200 nM,
Molecular Probes, Eugene, OR) or MitoTracker Deep Red (50 nM,
Molecular Probes, Eugene, OR) in the culture medium at 37 °C for
30 min. After labeling, the coverslips were washed with PBS and
observed in a microscope under green excitation ﬁlter to detect the
emission of LysoTracker or MitoTracker. Microscopy and photography
of control cells were performed using a BX61 epiﬂuorescence
microscope (Olympus, Tokyo, Japan). Photographs were processed
using Adobe Photoshop CS2 software (Adobe Systems, San Jose, CA).
Quantitative studies on HeLa cells subjected to 1 or 10 μM ZnTPP in
liposomes with and without folate were carried out using image
processing and analysis (IPA) from the public domain ImageJ 1.42
software (http://rsbweb.nih.gov/ij/index.html) [41]. The red ZnTPP
signal was recorded for each cell, brightness values in arbitrary units
corresponding to the following ratio: integrated density/area. Results
were the mean values and standard deviations from a total of 70
images. In addition, the frequency of brightness values (red signal)
was also evaluated for cells subjected to 24 h treatments with 1 or
10 μM ZnTPP in liposomes either with or without folate.
2.7. Photodynamic treatment in vitro
Folate-deﬁcient cells were seeded in 96-well plates and cultured
towards 80–85% conﬂuence. They were then incubated in the dark at
37 °C with FD-DMEM containing 0.1–10 μM ZnTPP encapsulated in the
two different liposomal formulations. After 24 h incubation, cells were
washed three times with PBS and replenish with fresh FD-DMEM.
Irradiation was carried out with a Sorisa Photocare LED source with a
wavelength range of 520–550 nm. The light intensity at the irradiation
site was 16 mW/cm2, measured with a LaserStar Ophir power meter
(Logan, UT, USA). Cells were irradiated for different times ranging from
2 min to 30 min and then incubated for 24 h before the MTT assay for
cell viability. Experiments were performed in triplicate.
2.8. Spectroscopic measurements
Absorption spectra were recorded on a Varian Cary 4E spectro-
photometer, equipped with a 110 mm-diameter integrating sphere
for transmittance measurements. Fluorescence emission and excita-
tion spectra were recorded in a Jobin-Ybon Specx Fluoromax-2
spectroﬂuorometer. The ﬂuorescence quantum yields were deter-
mined by comparison of the areas under the emission curves for
optically-matched suspension of liposomes and a reference, after
correcting for the refractive index of the solvent. ZnTPP in toluenewas
used as reference with ΦF=0.033 [42]. Fluorescence decays were
recorded in a time-correlated single photon counting system
(Fluotime 200, PicoQuant GmbH, Berlin, Germany) with a 596-nm
excitation LED. The ﬂuorescence decays were analyzed using the
PicoQuant FluoFit 4.0 data analysis software.
1O2 phosphorescence was detected using a customized PicoQuant
Fluotime 200 system described elsewhere [43,44]. Brieﬂy, a diode-
pumped pulsed Nd:YAG laser (FTSS355-Q, Crystal Laser, Berlin,
Germany) working at 10 kHz repetition rate at 532 nm (12 mW,
1.2 μJ per pulse) was used for excitation. A 1064 nm rugate notch ﬁlter
(EdmundOptics, UK)was placed at the exit port of the laser to remove
any residual component of its fundamental emission in the near-IR
region. The luminescence exiting from the side of the cuvette was
ﬁltered by a cold mirror (CVI Melles Griot, USA) to remove any
scattered laser radiation. A TE-cooled Hamammatsu near IR photo-
multiplier (model H9170-45), sensitive from 950 to 1400 nm, was
used to detect the 1O2 phosphorescence. The detector was operated in
photon counting mode and its output sent to a multichannel scaler
PicoQuant Nanoharp 250.
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ﬂash photolysis using a Q-switched Nd-YAG laser (Surelite I-10,
Continuum) with right-angle geometry and an analyzing beam
produced by a Xe lamp (PTI, 75 W) in combination with a dual-
grating monochromator (mod. 101, PTI) coupled to a photomultiplier
(Hamamatsu R928). Kinetic analysis of the individual transients was
achieved with the FitLW software developed in our laboratory.
For spectroscopic measurements in cell suspensions HeLa cells
were incubated in the dark with 10 μM ZnTPP encapsulated in folate-
targeted and non-targeted liposomes for 24 h. The medium was
discarded and the cells were washed three times with PBS, scrapped
and resuspended in 1.5 mL of PBS or D2O-based PBS (D-PBS). The
samples contained about 8 millions of cells in 1.5 mL of PBS and were
continuously stirred during the measurements. The measurements
were then carried out within the following 45 min.
All spectroscopic measurements were carried out in 1-cm quartz
cuvettes (Hellma, Germany), at room temperature and under
continuous stirring.
2.9. Statistical analysis
Unpaired Student's t test was used to test for the signiﬁcance level
between two sets of measurements. The level of signiﬁcance was set
to pb0.05.
3. Results and discussion
3.1. Characterization of liposomal formulations
FR-targeted and non-targeted liposomes containing ZnTPP at
100:1 lipid/porphyrin molar ratio were prepared by microemulsiﬁca-
tion. This particular combination of PS and lipids allows for a high
encapsulation of this PS [31]. The PS encapsulation efﬁcacy was close
to 90% and was not affected by folate functionalization. Photon
correlation spectroscopy (PCS) showed a dynamic diameter of
110 nm for non-targeted liposomes and 140 nm for FR-targeted
liposomes with a polydispersity index of 0.3. The stability of the
formulations was monitored by changes in the particle size and
porphyrin and lipid retention over one week storage at 4 °C in the
dark (Table 1). The liposomal formulations showed excellent colloidal
stability and drug retention during this period. We thus conclude that
the properties and stability of liposomal preparations are not affected
by the presence of the folate marker.
The phase transition temperature of POPC/OOPS (90:10) lipo-
somes was reported previously as−5.1±0.7 °C and was not affected
by the incorporation of 1% ZnTPP [31]. Thus, one can reasonably
expect that it won't be affected either by the presence of 0.1 mol% FA-
PEG-DSPE. The liposomes can therefore be safely assumed to be in the
ﬂuid state at 37 °C, temperature at which cell experiments wereTable 1
Stability of FR-targeted and non-targeted formulations as measured by lipid and PS
content, particle size and zeta potential.
Sample Time/h L (%)a P (%)b Zave/nmc ζ pot/mVd
Non-targeted 0 90±2 94±8 110±20 −38±5
24 97±9 85±10 130±30 −31±3
168 79±3 83±13 140±20 −30±3
FR-targeted 0 87±4 96±7 140±20 −36±2
24 97±12 93±4 130±30 −34±2
168 78±3 83±5 110±20 −35±4
Data are mean values±SD of at least three independent experiments.
a L: Lipid content, expressed as the percentage of lipid in the sample with respect to
the lipid present at the initial stage of liposome preparation.
b P: Porphyrin content, expressed as the percentage of porphyrin in the sample with
respect to the porphyrin present at the initial stage of liposome preparation.
c Z average mean.
d Zeta potential.carried out. In order to ensure that ZnTPP does not escape from
liposomes interacting with serum proteins, the stability of liposomes
was tested also in the presence of 10% FBS at 37 °C. The remaining PS
in both FR-targeted and non-targeted liposomal suspensions was
always above 90%, indicating that serum proteins do not affect
liposome stability and, especially, do not induce the release of the
entrapped ZnTPP (Table 1).
The same holds true for the photophysical properties of the
sensitizer: Fig. 1 shows the absorption and emission spectra of ZnTPP
encapsulated in folate-targeted liposomes and their non-targeted
counterparts. No spectral shifts can be observed between the two sets
of data, ruling out any signiﬁcant interaction of the porphyrinwith the
folate ligand. Likewise, the ﬂuorescence quantum yield of ZnTPP,
calculated by steady-state comparative method of optically-matched
solutions, was 0.025 and 0.024 for folate-targeted liposomes and non-
targeted liposomes, respectively (ΦF (ZnTPP, toluene)=0.033) [42].
Finally, the ﬂuorescence decay kinetics, determined by time-corre-
lated single photon counting, also conﬁrmed that the photophysics of
ZnTPP in the lipid bilayers are not affected by the presence of the FA-
PEG-DSPE ligand. The ﬂuorescence decay could be ﬁtted in both
systems by two exponential components with lifetimes 2.0±0.1 and
1.3±0.1 ns, respectively, reﬂecting different endoliposomal locations
of ZnTPP in the phospholipid bilayer [45].
3.2. Cellular uptake of FR-targeted liposomes
After conﬁrming that ZnTPP incorporation into the lipid bilayers is
not affected by the presence of the FA-PEG-DSPE ligand, the effect of
the folate marker on the cellular uptake of ZnTPP was determined.
HeLa and A549 cells were incubated for different times with 10 μM
ZnTPP encapsulated in folate-targeted and non-targeted liposomes.
The extent of PS uptake was then determined by ﬂuorescence
spectroscopy after lysing the cells and then normalized to the protein
content of each sample to correct for variations in the number of cells.
As shown in Fig. 2A, a clear differential uptake between folate-
targeted and non-targeted liposomes was observed. Thus, when FR-
overexpressing HeLa cells were incubated for 24 h with folate-
targeted liposomes, a 70% increase of lysate ﬂuorescence is observed
compared to the values for non-targeted liposomes. Moreover, FR-
deﬁcient A549 cells showed no differences in the liposomal
incorporation (Fig. 2B). These results conﬁrm that active uptake
mediated by folate receptors is an effective approach to increase the
uptake of PS encapsulated in folate-functionalized liposomes.
Additional evidence for the speciﬁc role of folate-receptor
interactions in the differential uptake of ZnTPP was obtained from
competitive binding assays. Thus, 1 mM folic acid was added to the
incubation medium to saturate the receptors on the cell surface. Fig. 3Fig. 1. Absorption (solid line) and emission (dashed line) spectra of ZnTPP incorporated
in folate-targeted liposomes (black) and non-targeted liposomes (grey) in 50 mM
imidazole–HCl buffer, pH 7.4. Note the factor ×10 in the 500–650 nm region of
absorption spectra. The spectra were corrected relative to absorption at 550 nm.
Fig. 2. Cellular uptake of ZnTPP encapsulated in folate-targeted liposomes (■) and non-targeted liposomes (△) by (A) HeLa and (B) A549 cells in folate-depleted DMEMmedia. The
ﬂuorescence change plotted is the ratio between the area under the ﬂuorescence emission and the protein content in each suspension. Mean±SD values from at least two different
experiments are shown. **pb0.01.
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uptake in HeLa cells targeted with liposomes bearing folate ligands
and no differences were observed between targeted and non-targeted
liposomes uptake, indicating that the contribution of folate receptors
to the uptake of ZnTPP was completely inhibited.
In a third series of experiments, the effect of FA-PEG-DSPE
liposomal content on the uptake of ZnTPP was also assessed. HeLa
cells were incubated for 24 h with different formulations containing
0–0.2 mol% of FA-PEG-DSPE and the ﬂuorescence of the cell lysate was
measured and normalized to the protein content of each sample. As
expected, uptake of ZnTPP was found to be notably dependent on the
amount of FA-PEG-DSPE present in the liposomes (Fig. 4). Increasing
amounts of the folate ligand led to higher uptake of the PS although
saturation effects were observed at the highest FA-PEG-DSPE
concentration assayed. Since FR can bind only one molecule of folic
acid [40], we chose to use 0.1 mol% FA-PEG-DSPE in all experiments,
which also precludes the formation of folate dimers and trimers [46].
Thus, we can ensure an efﬁcient interaction with folate receptors.
To check whether the incubation at 4 °C prevents ZnTPP uptake, the
cell-surface binding capacity of folate-targeted and non-targeted
liposomes was estimated from the differential uptake of ZnTPP by
HeLa cells incubated at 4 °C or 37 °C (Fig. 5). In both cases, the extent of
PS uptake was dramatically reduced when the incubation of ZnTTP-
containing liposomes was performed at 4 °C, suggesting that endocy-
tosis is the main cell internalization mechanism. Moreover, at this low
temperature, almost a two-fold increase of cell-lysate ﬂuorescence was
observed for folate-targeted liposomes compared to non-targeted ones.
This indicates that the differential uptake between folate-targeted and
non-targeted liposomes is ampliﬁed due to enhanced surface binding of
the former.Nevertheless, anacidicwashof the cells caused the release of
surface-bound folate-targeted liposomes, showing that the uptake dueFig. 3. Competitive binding assay in HeLa cells cultured with FR-targeted and non-
targeted liposomes, with or without the addition of 1 mM free folic acid. The
enhancement of the FR-targeted liposomes uptake was totally inhibited in the presence
of 1 mM free folic acid. Fluorescence emission was normalized with protein content of
each suspension. Mean±SD values from at least two different experiments are shown.
**pb0.01.to binding to the folate receptor was greatly diminished under such
acidic conditions [23,39,40].
Taking all these results together, the preferential uptake of folate-
targeted liposomes was demonstrated in HeLa cells. Nevertheless, the
differences observed were smaller than expected [23,47,48]. More-
over, non-targeted liposomes are also internalized, revealing that
non-speciﬁc endocytosis also contributes to the uptake. Qualls and
Thompson [26] also observed non-speciﬁc liposomal uptake path-
ways when KB cells, also overexpressing folate receptors [24], were
treated with AlPcS44− encapsulated in folate-displasmenylcholine
liposomes.
3.3. Photosensitization experiments
Studies on the efﬁciency of the FR-targeted liposomes for PDT are
summarized in Figs. 6 and 7. A549 and HeLa cells were incubated in
the dark with different concentrations of ZnTPP entrapped in FR-
targeted and non-targeted liposomes for 24 h prior to photosensiti-
zation. Afterwards, cells were exposed to green light using a LED
source. Cell survival was assessed by MTT assay 24 h after treatment.
Dark cytotoxicity experiments yielding survival cell fraction higher
than 85% demonstrated that incubation with FR-targeted and non-
targeted liposomes at the concentrations used did not induce
signiﬁcant cell death without irradiation. Fig. 6 shows the light and
concentration dependence of the photodynamic response of HeLa
cells for both types of ZnTPP-loaded liposomes. As expected,
increasing the light dose and the concentration of the PS led to
enhanced photocytotoxicity. Folate-decorated liposomes consistentlyFig. 4. Uptake of ZnTPP encapsulated in folate-targeted formulations with varying
percentages of FA-PEG-DSPE by HeLa cells. Cells were incubated for 24 h with non-
targeted liposomes (0 mol% FA-PEG-DSPE) or folate-targeted liposomes with the FA-
PEG-DSPE mole percentage ranging from 0.02 to 0.2. Fluorescence emission was
normalized with protein content of each suspension. The ﬂuorescence emission plotted
is relative to the lysate ﬂuorescence of cells treated with non-targeted liposomes. The
lysate ﬂuorescence corresponding to 0 mol% FA-PEG-DSPE was normalized to 0±12%.
Mean±SD values from at least three different experiments are shown.
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Fig. 5. Temperature-dependent uptake of ZnTPP encapsulated in folate-targeted and
non-targeted liposomes. Cells were incubated for 4 h at 37 °C or 4 °C. The cells were
then washed with cold PBS or with acidic saline buffer to remove unattached liposomes
or either stripped of surface-bound liposomes. Fluorescence emission was normalized
with protein content of each suspension. The ﬂuorescence emission plotted is relative
to the mean lysate ﬂuorescence of cells treated with folate-targeted liposomes at 37 °C,
normalized to 100±14%. Mean±SD values from at least three different experiments
are shown.
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alone or incubated with empty liposomes did not induce any toxicity.
A better appreciation of the folate-labeling effects can be gained
by comparing the photodynamic effect under the same conditions.
Thus, for 1 μM ZnTPP incubated for 24 h in A549 and HeLa cells
and irradiated with 10 J cm−2 (Fig. 7), non-targeted liposomes
caused 65±5% cell death in both cell lines. The use of FR-targeted
liposomes increased the cellmortality to 94±5% for FR-positive HeLa
cells, while it remained at 60±5% for FR-negative A549 cells. Thus
folate-targeted liposomes enhanced cell mortality by 50% in FR-
positive HeLa cells.Fig. 6. Concentration and irradiation time dependence of photocytotoxicity of ZnTPP encap
The concentrations represented are (●) 0.1 μM, (■) 1 μM and (▲) 10 μM. Mean±SD from
Fig. 7. Photodynamic induced cytotoxicity of ZnTPP encapsulated in (A) non-targeted liposo
different experiments are shown. ***pb0.001.3.4. Subcellular localization
Fluorescence and differential interference contrast images of HeLa
cells after 24 or 48 h incubationwith folate-targeted and non-targeted
liposomes (10 μM ZnTPP bulk concentration) are shown in Fig. 8. The
cells displayed a pattern of intense granular signal in the cytoplasm.
The site of ZnTPP accumulation strongly resembled that of acidic
organelles and therefore, lysosomes could be the main site of ZnTPP
accumulation. Additionally, the intracellular localization of ZnTPPwas
compared with the distribution of ﬂuorescent probes speciﬁc to
lysosomes (LysoTracker Red) and to mitochondria (MitoTracker Red).
LysoTracker and Mitotracker Red probes are commonly used in
several research areas, including PDT studies [49–52]. As shown in
Fig. 8A, the intracellular distribution of ZnTPP was clearly similar to
LysoTracker Red, and clearly different from the mitochondrial
network displayed with MitoTracker Red, under green excitation
epiﬂuorescence microscopy. We could not observe the co-localization
of ZnTPP and LysoTracker probe because of the red emission of both
dyes. The intensity of the punctate ﬂuorescence was dependent on the
porphyrin concentration, incubation time, as well as ZnTPP liposomal
formulation. It is important to note that no morphological changes
were detected in the cells under these conditions and no relocaliza-
tion of the PS was observed when cells were exposed to prolonged
exciting light. Non-speciﬁc adsorptive endocytosis pathway was
conﬁrmed by the fact that the intracellular localization of ZnTPP by
non-targeted liposomes was identical to that of liposomes with folate.
Cells treated with 10 μM ZnTPP vehiculizated in liposomes with
folate appeared with a higher ﬂuorescence signal in relation to folate-
free liposomes (see Fig. 8A). These results were conﬁrmed by the
quantitative analysis of ﬂuorescence intensity using ImageJ 1.42
software (Fig. 8B and C), and results are consistent with the cellular
uptake measured by cell lysate ﬂuorescence.sulated in (A) non-targeted liposomes and (B) folate-targeted liposomes by HeLa cells.
at least three different experiments are shown.
mes and (B) folate-targeted liposomes (1 μM, 10 J/cm2). Mean±SD from at least three
Fig. 8. (A) Confocal microscopy images of living HeLa cells incubated 24 or 48 hwith different liposomal formulations of 10 μMZnTPP. (a) and (b) Subcellular localization of ZnTPP in
HeLa cells incubated 24 h in liposomes without andwith folate, respectively. (c) and (d) Cells displaying the ﬂuorescence pattern of ZnTPP 48 h after incubation in liposomes without
and with folate, respectively. All images are the overlay of the ﬂuorescence signal and differential interference contrast (DIC). Scale bar: 10 μm. (e) Localization of MitoTracker Red in
HeLa control cells. (f) Localization of LysoTracker Red in HeLa control cells. (B) and (C)Microscopical evaluation of ZnTPP uptake. B: Mean brightness values (±SD) of the signal from
HeLa cells treated for 24 h with 1 or 10 μM ZnTPP in liposomes with (F+) or without (F−) folate. C: Distribution of brightness values from HeLa cells subjected to 24 h treatments
with both 1 and 10 μM ZnTPP in liposomes either with or without folate.
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encapsulated in FR-targeted and non-targeted liposomes
In a typical experiment, 1.5 mL-D2O-based PBS (D-PBS) cell
suspension containing ~8×106 cells incubated with ZnTPP encapsu-
lated in FR-targeted and non-targeted liposomes was assayed for 1O2
using pulsed laser excitation at 532 nm and observing the 1O2
phosphorescence at 1280 nm. Indeed, the samples produced clearFig. 9. Time-resolved luminescence decays of 1O2 recorded at 1280 nm upon 532 nm
excitation of a D-PBS HeLa cell suspension, previously incubated with 10 μM ZnTPP
encapsulated in (a) non-targeted and (b) folate-targeted liposomes during 24 h in the
dark. A: Fitted parameters: τ1=1.5±0.4 μs, τ2=5.8±0.5 μs; Inset A: ΔAbs signal
recorded at 470 nm (triplet absorption), ﬁtted parameters: τ1=5±1 μs; B: ﬁtted
parameters: τ1=1.5±0.4 μs, τ2=6.1±0.5 μs.1O2 phosphorescence signals showing the expected rise-and-decay
shape (Fig. 9). Kinetic analysis of the data in Fig. 9 yielded lifetimes
τ1=1.5±0.4 μs for the rise and τ2=6.0±0.5 μs for the decay, the
same results being obtained for both FR-targeted and non-targeted
liposomes. Thus, the kinetics of 1O2 production and decay in HeLa cells
are not affected by the presence of folate ligands on the surface of the
liposomes used for delivery of the ZnTPP, suggesting a similar ﬁnal
localization of the PS, in agreement with the confocal microscopy
results.
The inset in Fig. 9A shows the transient absorbance of 3ZnTPP in
the cell suspension. Kinetic analysis of this signal yields τT=5±1 μs,
which means that τΔ=1.5±0.4 μs in HeLa cells. This lifetime is much
shorter than the typical value in D2O (60–70 μs, [53]) indicating that
1O2 is substantially quenched in these cells. Given diffusion coefﬁ-
cients of singlet oxygen in the 0.4–2×10−5 cm2s−1 range [54–56]
and the typical size of the lysosomes (50–500 nm), it can be safely
concluded that primary 1O2 damage will be conﬁned to this organelle,
as found previously in human skin ﬁbroblasts [44]. Indeed, we were
not able to quench 1O2 with standard quenchers such as sodium azide
or bovine serum albumin.
4. Conclusions
A novel folate-targeted liposomal formulation of the model PS
ZnTPP has been developed for its selective delivery to FR-over-
expressing cancer cells. The stability of liposomal formulations and
the photophysical properties of the PS are not affected by the presence
of the folate ligand. This folate-targeted formulation shows enhanced
ZnTPP internalization and phototoxicity by folate-receptor-positive
cells, although non-speciﬁc pathways are also involved in cellular
uptake. Confocal microscopy and 1O2 kinetics measured in living cells
indicate a lysosome localization of ZnTPP in HeLa cells, irrespective of
the presence of folate on the liposome surface.
The prevention of liposome uptake at low temperature accounts for
the involvement of endocytic pathways in the cellular internalization of
1070 M. García-Díaz et al. / Biochimica et Biophysica Acta 1808 (2011) 1063–1071both targeted and non-targeted liposomes. Moreover, the reduction of
ZnTPP ﬂuorescence in the cells' lysates after an acidicwash conﬁrms the
interaction of the folate-targeted liposomes with the receptors. These
observations are consistent with the lysosomal localization of ZnTPP.
Taken together, our results suggest that folate ligands enhance the
cellular uptake in FR-positive cells mainly as a result of a sustained
contact between the liposome and the cell surface, thereby increasing
the liposomes' ability to internalize drugs. It will be interesting to see
whether in cells with higher FR overexpression this folate-induced
selectivity can be further increased. In addition, it will be interesting
to study the efﬁcacy of FR-targeted liposomes in preclinical models
and their potential for future clinical application in photodynamic
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